The role of the Clinical Trials Conduct Unit (CTCU) is to conduct clinical studies in a professional manner, in compliance with European Directives, regulations and Good Clinical Practice – GCP). These clinical studies are carried out in collaboration with pharmaceutical firms and/or academic partners. The Institut Bordet also implements its own clinical studies.
Clinical studies are very closely monitored and must meet the quality criteria essential for ensuring that patients who participate in the studies are protected, while also maintaining a very high level of medical care. The CTCU and the different medical departments maintain very close links. Patient well-being is always our key concern.
The clinical studies conducted at the Institut Bordet are coordinated by CTCU research physicians and teams. These doctors are responsible for monitoring patients and collecting data.
Each year, the CTCU welcomes and supervises students as part of their training (nurses, pharmacists, PhD students).
In addition, our researchers supervise young trainee doctors in clinical research on a weekly basis. Also, twice a year, Dr Aftimos gives a course on clinical studies for these young doctors.
Our researchers participate as speakers in the “Midis des Amis” lecture series.
Développement d’un outil informatique assurant l’amélioration du recueil des données cliniques relatives à la recherche (effets secondaires, médicaments concomitants, histoire médicale du patient)
Under the responsibility of the research physician, the clinical research nurses and clinical study coordinators organise and coordinate the different aspects of the clinical studies. They are the point of contact for patients participating in clinical trials and also for all our research partners. They provide personalised support for the patient and are the primary contact throughout treatment.
Explanation of roles:
- The principal researcher is a doctor who manages the execution of the clinical trial on our site. He undertakes to conduct the research in accordance with good clinical practice and in line with the protocol. He appoints his collaborators and determines their role in the study.
- The co-researchers are doctors who include and inform the patients in the trials. They are responsible for monitoring patients, in accordance with the protocol, and for the collection of data.
- The research nurses and clinical study coordinators assist the researchers throughout the trial. Their role is to inform patients, manage appointment planning, gather information, manage communication between the different parties involved in the study and to implement the technical requirements of the protocol. They are the point of contact for the patient, researchers and those promoting the study.
- The data managers are the encoders who assist the study coordinators in providing information relating to the clinical trials to the promoter of the study (a pharmaceutical firm or academic centre).
- The administrative & start-up coordinator is an administrative assistant who assists the researcher in setting up all new research projects at the Institut Bordet.
- The quality assistant implements and manages standardised operating procedures to facilitate the execution of quality clinical trials, in accordance with the rules of good clinical practice. She designs and implements the methods and tools by which the CTCU is able to ensure that quality is maintained and evolves.
Head of the CTCU
Administrative & start up coordinator
Thi Diem Chi Nguyen
Research nurses/clinical study coordinators
- For Medical Oncology and Radiotherapy
Nathalie De Naeijer
- For Haematology
Anne De Meûter
Dominique De Poorter
- For Thoracic Oncology, Oncological Emergencies and Intensive Care
- For Infectology
- For Nuclear Medicine
Loubna Taraji Schiltz
Le cancer du sein ne disparaîtra pas mais aider la recherche c'est aider à ce qu'il ne tue plus.
Cancer du sein : l'oncologue Martine Piccart à l'honneur
- Foodinaction. 6 Janvier 2016
Des chercheurs belges préparent un traitement révolutionnaire contre le cancer
- 11 Janvier 2017 – Dr Awada (RTL INFO)
Programme PRECISION, commentaires du Dr Philippe Aftimos
- Belgian Oncology - 17/12/14
Economie de la santé : 14% de chimiothérapies inutiles ?
- Le Journal Du Médecin - 16/12/16
Cancer : une thérapie ciblée sur le profil de la tumeur
- Journal en ligne : L'ECHO - 8/5/2015